IBM vs INTC

IBM trades at a premium valuation with solid historical profitability and consistent earnings beats, supported by strong ROE of 30.16% and a 9.1% YoY revenue growth. However, elevated P/E of 36.48 and forward P/E of 28.81 exceed both peer averages and historical norms, while weakening near-term EPS momentum—evidenced by a -5.4% Q/Q decline—raises concerns about sustainability. The stock has delivered strong price performance over 5Y (+232.3%) and 1Y (+50.0%), reflecting investor confidence in its hybrid cloud and AI转型, though leverage remains high at 2.38x Debt/Equity. Analysts broadly concur with a 'hold' recommendation, and absent insider activity, the setup appears balanced between proven execution and stretched near-term expectations.

Intel's deterministic health is stable with a Piotroski F-Score of 6/9, but this is overshadowed by a severe divergence between price and fundamentals. While the stock has seen a massive 1-year rally (+234.6%), the company is struggling with negative profit margins (-0.51%), declining revenue (-4.10%), and a catastrophic YoY EPS collapse of -300%. With the current price of $65.27 trading significantly above the analyst target of $55.33 and a technical trend score of 10/100, the stock appears overextended and fundamentally unsupported.